Offen D - Search Results

1

Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.

Offen D, Sherki Y, Melamed E, Fridkin M, Brenneman DE, Gozes I. Offen D, et al. Brain Res. 2000 Jan 31;854(1-2):257-62. doi: 10.1016/s0006-8993(99)02375-6. Brain Res. 2000. PMID: 10784133

2

Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease.

Ziv I, Melamed E, Nardi N, Luria D, Achiron A, Offen D, Barzilai A. Ziv I, et al. Among authors: offen d. Neurosci Lett. 1994 Mar 28;170(1):136-40. doi: 10.1016/0304-3940(94)90258-5. Neurosci Lett. 1994. PMID: 8041491

3

Dopamine-induced, genotoxic activation of programmed cell death. A role in nigrostriatal neuronal degeneration in Parkinson's disease?

Ziv I, Barzilai A, Offen D, Stein R, Achiron A, Melamed E. Ziv I, et al. Among authors: offen d. Adv Neurol. 1996;69:229-33. Adv Neurol. 1996. PMID: 8615132 Review. No abstract available.

4

Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease.

Offen D, Ziv I, Sternin H, Melamed E, Hochman A. Offen D, et al. Exp Neurol. 1996 Sep;141(1):32-9. doi: 10.1006/exnr.1996.0136. Exp Neurol. 1996. PMID: 8797665

5

Levodopa induces apoptosis in cultured neuronal cells--a possible accelerator of nigrostriatal degeneration in Parkinson's disease?

Ziv I, Zilkha-Falb R, Offen D, Shirvan A, Barzilai A, Melamed E. Ziv I, et al. Among authors: offen d. Mov Disord. 1997 Jan;12(1):17-23. doi: 10.1002/mds.870120105. Mov Disord. 1997. PMID: 8990049

6

Monoamine-induced apoptotic neuronal cell death.

Zilkha-Falb R, Ziv I, Nardi N, Offen D, Melamed E, Barzilai A. Zilkha-Falb R, et al. Among authors: offen d. Cell Mol Neurobiol. 1997 Feb;17(1):101-18. doi: 10.1023/a:1026333222008. Cell Mol Neurobiol. 1997. PMID: 9118202

7

Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease.

Offen D, Ziv I, Barzilai A, Gorodin S, Glater E, Hochman A, Melamed E. Offen D, et al. Neurochem Int. 1997 Aug;31(2):207-16. doi: 10.1016/s0197-0186(96)00150-7. Neurochem Int. 1997. PMID: 9220453

8

Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process?

Ziv I, Barzilai A, Offen D, Nardi N, Melamed E. Ziv I, et al. Among authors: offen d. J Neural Transm Suppl. 1997;49:69-76. doi: 10.1007/978-3-7091-6844-8_7. J Neural Transm Suppl. 1997. PMID: 9266415 Review.

9

Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?

Ziv I, Offen D, Barzilai A, Haviv R, Stein R, Zilkha-Falb R, Shirvan A, Melamed E. Ziv I, et al. Among authors: offen d. J Neural Transm Suppl. 1997;49:195-202. doi: 10.1007/978-3-7091-6844-8_20. J Neural Transm Suppl. 1997. PMID: 9266428 Review.

10

Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity.

Offen D, Beart PM, Cheung NS, Pascoe CJ, Hochman A, Gorodin S, Melamed E, Bernard R, Bernard O. Offen D, et al. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5789-94. doi: 10.1073/pnas.95.10.5789. Proc Natl Acad Sci U S A. 1998. PMID: 9576963 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results